Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder

NCT06704594 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

288

Enrollment

OTHER

Sponsor class

Conditions

Premenstrual Dysphoric Disorder (PMDD)

Interventions

DRUG: sertraline 50 mg daily
DRUG: Placebo Oral Tablet

Sponsor

Johns Hopkins University

Collaborators

[object Object]